2.3.1.303: alpha-L-Rha-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-alpha-D-Gal-PP-Und 2IV-O-acetyltransferase
This is an abbreviated version!
For detailed information about alpha-L-Rha-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-alpha-D-Gal-PP-Und 2IV-O-acetyltransferase, go to the full flat file.
Reaction
Synonyms
orf14.9, rfbL, wbaL
ECTree
Advanced search results
Results | in table |
---|---|
1 | Application |
2 | General Information |
2 | Natural Substrates/ Products (Substrates) |
5 | Organism |
1 | Pathway |
1 | Reaction |
4 | Reference |
2 | Substrates and Products (Substrate) |
7 | Synonyms |
1 | Systematic Name |
Application
Application on EC 2.3.1.303 - alpha-L-Rha-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-alpha-D-Gal-PP-Und 2IV-O-acetyltransferase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
medicine
-
construction of bivalent vaccines for preventing both Salmonella typhimurium and Salmonella newport infections by using the aspartate semialdehyde dehydrogenase-based balanced-lethal vector-host system. The constructed plasmid pCZ11 carrying a subset of the Salmonella newport O-antigen gene cluster including the wzx-wbaR-wbaL-wbaQ-wzy-wbaW-wbaZ genes is introduced into Salmonella typhimurium. Upon deletion of the crp gene for attenuation purposes, BALB/c mice are orally immunized with the strains. Compared with a mock immunization, immunization with the vaccine strains induces significant serum IgG responses against both Salmonella typhimurium and Salmonella newport lipopolysaccharide